Biotech · Private company
Theracos
Track this companyFree. Adds Theracos to your Dealase workspace and tells you when its record changes.
Clinical trials190 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline19
- BexagliflozinPhase 3 · Essential HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- BexagliflozinPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Bexagliflozin tablets, 20 mgPhase 3 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GlimepiridePhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- SitagliptinPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Bexagliflozin tabletsPhase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- EGT0001442Phase 2 · Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- EGT0001442Phase 2 · Diabetes Mellitus Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- BexagliflozinPhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- DigoxinPhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- EGT0001474Phase 1 · Safety and Tolerability of EGT0001474 in Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- EGT0001474Phase 1 · Diabetes Mellitus Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- Exenatide InjectionPhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- GlimepiridePhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ProbenecidPhase 1 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- RifampinPhase 1 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- SitagliptinPhase 1 · Type2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- VerapamilPhase 1 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- Absolute Bioavailability Study With BexagliflozinPHASE1 · WITHDRAWN · started Aug 1, 2018ClinicalTrials.gov NCT03417076 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic ImpairmentPHASE1 · COMPLETED · started Jul 26, 2018ClinicalTrials.gov NCT03557658 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsPHASE3 · COMPLETED · started Nov 28, 2017ClinicalTrials.gov NCT03259789 · fetched Nov 12, 2026
- An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential HypertensionPHASE2_PHASE3 · COMPLETED · started Oct 18, 2017ClinicalTrials.gov NCT03514641 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsPHASE3 · COMPLETED · started Oct 12, 2017ClinicalTrials.gov NCT03115112 · fetched Nov 12, 2026
- Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy SubjectsPHASE1 · COMPLETED · started Sep 27, 2017ClinicalTrials.gov NCT03296800 · fetched Nov 12, 2026
- Bexagliflozin Drug/Drug Interaction Study With DigoxinPHASE1 · COMPLETED · started Jul 24, 2017ClinicalTrials.gov NCT03197324 · fetched Nov 12, 2026
- Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionPHASE1 · COMPLETED · started May 24, 2017ClinicalTrials.gov NCT03167411 · fetched Nov 12, 2026
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinPHASE1 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02956044 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentPHASE3 · COMPLETED · started Sep 23, 2016ClinicalTrials.gov NCT02836873 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsPHASE3 · COMPLETED · started Aug 15, 2016ClinicalTrials.gov NCT02769481 · fetched Nov 12, 2026
- Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy SubjectsPHASE1 · COMPLETED · started Jun 20, 2016ClinicalTrials.gov NCT02820298 · fetched Nov 12, 2026
- Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesPHASE3 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02715258 · fetched Nov 12, 2026
- Bexagliflozin Efficacy and Safety TrialPHASE3 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02558296 · fetched Nov 12, 2026
- A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started May 12, 2015ClinicalTrials.gov NCT02390050 · fetched Nov 12, 2026
- Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01377844 · fetched Nov 12, 2026
- Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01029704 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 DiabetesPHASE1 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00924053 · fetched Nov 12, 2026
- Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy VolunteersPHASE1 · COMPLETED · started Feb 1, 2009ClinicalTrials.gov NCT00854113 · fetched Nov 12, 2026